kelly mason

Kelly Mason has over 30 years of work experience in various accounting and finance roles. kelly is currently the Senior Director of Corporate Controller at A2 Biotherapeutics, Inc., a position they have held since December 2022. Prior to that, they served as the Director of Accounting at the same company starting in January 2021. Before joining A2 Biotherapeutics, Kelly worked as a Consultant from January 2020 to January 2021. kelly was previously the Director of Accounting at Sienna Biopharmaceuticals from January 2017 to December 2019. Kelly also has experience as an Accounting Manager at CDTi Advanced Materials, Inc. from May 2016 to January 2017. Prior to that, they were a Senior Manager of Accounting at KYTHERA Biopharmaceuticals from February 2012 to February 2016. kelly started their career as an Outside Consultant at Amgen from 2002 to 2007. Kelly also worked at Amgen as an Accounting Manager from March 1992 to July 2001, where they were responsible for various accounting and reporting tasks, including SEC reporting, budgeting, and clinical trial accruals. kelly began their career at KPMG US as a Supervising Senior from September 1987 to March 1992.

Kelly Mason attended California Lutheran University from 2009 to 2011, but did not complete a degree or specify a field of study during that time. From 1983 to 1986, they studied at Colorado State University and obtained a Bachelor of Science degree in Accounting. Prior to that, from 1981 to 1983, they attended Illinois State University but did not complete a degree, focusing on Business as their field of study. Furthermore, there is no information available regarding any obtained certifications, such as the Certified Public Accountant certification from the State of California.